Centenial Surgical Suture Limited (CSURGSU.BO)
INR 145.0
(-0.03%)
INR 145.0
(-0.03%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 37.45 Million | 12.95 Million | 47.5 Million | 19.68 Million | 20.78 Million | 15.47 Million |
| Net Income | 11.34 Million | 14.62 Million | 10.74 Million | 15.29 Million | 21.55 Million | 28.41 Million |
| Depreciation & Amortization | 13.87 Million | 12.99 Million | 15.26 Million | 15.5 Million | 15.53 Million | 6.94 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 12.71 Million | -25.99 Million | 5.48 Million | -26.09 Million | -6.2 Million | -12.02 Million |
| Other non-cash items | -9.82 Million | 11.32 Million | 16.01 Million | 14.97 Million | -10.09 Million | -7.86 Million |
| Investing Cash Flow | -79.19 Million | -1.75 Million | -1.66 Million | -8.86 Million | -13.08 Million | -10.21 Million |
| Investments in PPE | -76.96 Million | -1.61 Million | -1.57 Million | -8.38 Million | -10.79 Million | -9.82 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 164 Thousand | - |
| Other Investing Activities | -2.23 Million | -146 Thousand | -91 Thousand | -483 Thousand | -2.45 Million | -393 Thousand |
| Financing Cash Flow | 45.28 Million | -10.46 Million | -48.66 Million | -12.66 Million | -3.73 Million | -12.71 Million |
| Debt repayment | -45.28 Million | -16.64 Million | -29.74 Million | -7.5 Million | -3.73 Million | -12.71 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1000.00 | 6.17 Million | -18.92 Million | -5.15 Million | - | - |
| Accounts receivables | 17.89 Million | -10.67 Million | 28.74 Million | 9.51 Million | -26.48 Million | -26.07 Million |
| Accounts payables | 71.93 Million | 35.45 Million | -64.02 Million | 244 Thousand | 46.8 Million | 7.16 Million |
| Inventory | -52.72 Million | -49.78 Million | 39.67 Million | -40.33 Million | -23.77 Million | 7.51 Million |
| Other working capital | -24.38 Million | -996 Thousand | 1.08 Million | 4.48 Million | -2.76 Million | -633 Thousand |
| Cash at beginning of period | 3.3 Million | 2.56 Million | 5.38 Million | 7.22 Million | 3.26 Million | 10.72 Million |
| Cash at end of period | 6.84 Million | 3.3 Million | 2.56 Million | 5.38 Million | 7.22 Million | 3.26 Million |
| Capital Expenditure | -76.96 Million | -1.61 Million | -1.57 Million | -8.38 Million | -10.79 Million | -9.82 Million |
| Effect of forex changes on cash | - | 1000.00 | - | - | - | - |
| Net cash flow / Change in cash | 3.54 Million | 735 Thousand | -2.82 Million | -1.84 Million | 3.96 Million | -7.46 Million |
| Free Cash Flow | -39.5 Million | 11.34 Million | 45.93 Million | 11.3 Million | 9.99 Million | 5.65 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 11.34 Million | 3.06 Million | 2.36 Million | 2.91 Million | 14.62 Million | 1.4 Million |
| Depreciation & Amortization | 13.87 Million | 3.3 Million | 3.19 Million | 3 Million | 12.99 Million | 3.09 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 12.71 Million | - | - | - | -25.99 Million | - |
| Other non-cash items | -9.82 Million | 245 Thousand | -3.19 Million | -3 Million | 11.32 Million | -3.09 Million |
| Investing Cash Flow | -79.19 Million | - | - | - | -1.75 Million | - |
| Investments in PPE | -76.96 Million | - | - | - | -1.61 Million | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.23 Million | - | - | - | -146 Thousand | - |
| Financing Cash Flow | 45.28 Million | - | - | - | -10.46 Million | - |
| Debt repayment | -45.28 Million | - | - | - | -16.64 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1000.00 | - | - | - | 6.17 Million | - |
| Accounts receivables | 17.89 Million | - | - | - | -10.67 Million | - |
| Accounts payables | 71.93 Million | - | - | - | 35.45 Million | - |
| Inventory | -52.72 Million | - | - | - | -49.78 Million | - |
| Other working capital | -24.38 Million | - | - | - | -996 Thousand | - |
| Cash at beginning of period | 3.3 Million | 4.69 Million | 2.32 Million | 3.3 Million | 2.56 Million | 1.89 Million |
| Cash at end of period | 6.84 Million | 11.3 Million | 4.69 Million | 2.91 Million | 3.3 Million | 3.3 Million |
| Capital Expenditure | -76.96 Million | - | - | - | -1.61 Million | - |
| Effect of forex changes on cash | - | - | - | - | 1000.00 | - |
| Net cash flow / Change in cash | 3.54 Million | 6.61 Million | 2.36 Million | -383 Thousand | 735 Thousand | 1.4 Million |
| Free Cash Flow | -39.5 Million | 6.61 Million | 2.36 Million | 2.91 Million | 11.34 Million | 1.4 Million |
GPTGF
TXIC
VSCO
SHMM
ALHGR
ELEMF